Here are relevant reports on : sports-medicine-market
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Electroceuticals Market / Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) & Region - Global Forecast to 2029
The global electroceuticals market, valued at US$21.9 billion in 2023, stood at US$23.9 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Growth of the overall market is largely driven by the increasing incidence of cardiovascular, hearing loss and neurological disorders, increasing research in these field of disorders, and rising awareness regarding electroceuticals devices.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), & End User (CROs) - Forecast to 2030
The Asia Pacific nucleic acid isolation and purification market, valued at USD1.49 billion in 2024, stood at USD1.61 billion in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2025 to 2030, culminating in a forecasted valuation of USD2.65 billion by the end of the period. The Asia Pacific market for nucleic acid isolation and purification is expanding due to the increasing number of molecular tests and the scale-up of PCR and NGS across the region.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
US Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The US artificial intelligence (AI) in healthcare market, valued at US$5.98 billion in 2024, stood at US$8.65 billion in 2025 and is projected to advance at a resilient CAGR of 38.0% from 2025 to 2030, culminating in a forecasted valuation of US$43.30 billion by the end of the period. Market growth is driven by rising demand from providers for automation, nationwide labor shortages, increasing clinical complexity, and strong investment in predictive analytics, imaging AI, and GenAI.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Precision Medicine Software Market by Delivery Mode (On-Premise & Cloud-Based), End User (Healthcare Providers, Research Centers & Government Institutes, Pharmaceutical & Biotechnology Companies), Application, and Region - Global Forecast to 2024
The precision medicine software market is projected to reach USD 2.0 billion by 2024, at a CAGR of 11.5%. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. However, the high cost of deployment, issues related to the secure storage of large volumes of sequenced data, lack of reimbursement for precision medicine-based treatments, and the dearth of skilled IT professionals in healthcare are expected to restrain market growth to a certain extent in the coming years. Syapse, Inc. (US), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (US), Fabric Genomics (US), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (US), N-of-One, Inc. (US), Human Longevity, Inc. (US), Translational Software, Inc. (US), Sunquest Information Systems Inc. (US), Gene42, Inc. (Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands)
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Fluorometer Market by Light source (Lamps, LEDs, Diode Lasers, and Lasers), Application (Chemistry/Biochemistry, Medicine & Others), and End User (Hospitals, Pharmaceutical and Biotechnology Firms & CROs, Others) - Global Forecast to 2023
The global Fluorometer market is expected to reach USD 668.2 million by 2023 from USD 521.1 million in 2018, growing at a CAGR of 5.1%. Increasing incidence of cancer, advancement in cancer diagnostics, technological advancement in fluorometry are some of the major factors driving the growth of the global fluorometer market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
8K Technology Market by Product (Television (OLED, LED-LCD, QD-LCD, Micro-LED), Monitor & Notebook, Professional Camera, Projector), End User (Consumer, Sports & Entertainment, Medical), and Geography - Global Forecast to 2025 - 2036
The 8K technology market was valued at USD 12.28 billion in 2024 and is estimated to reach USD 102.46 billion by 2036, at a CAGR of 18.2% between 2025 and 2036. Demand for 8K technology is rising due to the increased demand for larger-sized TVs with higher resolution; availability of various products for the creation and delivery of 8K content; and advancements in display technology, financial assistance by governments, and expansion of production capabilities for 8K UHD display panels. Samsung Electronics (South Korea), LG Electronics (South Korea), Sony Corporation (Japan), JVCKENWOOD Corporation (Japan), Sharp Corporation (Japan), Canon Inc. (Japan), Red Digital Cinema (US), Dell Technologies (US), Leyard Optoelectronic (China), and Digital Projection (UK) are the major players in the 8K technology market.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Medium Chain Triglycerides Market by Fatty Acid Type (Caproic, Caprylic, Capric and Lauric), Application (Nutritional Supplements, Infant Formula, Sports Drinks, Pharmaceutical Products), Form, Source and Region - Global Forecast to 2026
The medium chain triglycerides market was expected to grow from USD 763 million in 2021 to USD 1034 million by 2026, at a CAGR of 6.3% during the forecast period. Key players in this market include BASF SE (Germany), Koninklijke DSM N.V. (the Netherlands), Dupont(US), Lonza Group Ltd(Switzerland), Musim Mas Holdings(Singapore), Croda International Plc(UK), P&G Chemicals (US), Acme-Hardesty Company(Bluebell, PA), Wilmar International Limited( Singapore), Stepan Company (US), Sternchemie GmbH & Co. KG(Germany), Emery Oleochemicals Group(US), KLK Oleo(Malaysia), Nutricia(New Zealand), Connoils (US), Now foods(US), Barleans (Washington), Jarrow formula’s(US), Nutiva(US), Henry Lamotte Oils GmbH (Germany).
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Sports Electronic Market - By Components (Sensors, Networking, Memory, Display, Speech Recognition); Products (Wrist-Wear, Eye-Wear, Foot-Wear, Body-Wear), Application, & Geography - Analysis and Forecast (2014-2020)
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Virtual Retinal Display Market by End-User Industry (Aviation & Tactical, Engineering, Medical, Gaming & Entertainment, Sports, Training & Development, and Others) and Geography - Trends and Forecast to 2016 - 2025
The virtual retina display technology is expected to be commercialized in 2016. The market is estimated to be worth USD 2.30 Million by 2016 and grow at CAGR of 45.28% between 2016 and 2025. The market is segmented based on end-user industries and geography. The demand in the gaming & entertainment industry is expected to drive the market growth in all regions– North America, Europe, APAC, and RoW.
- Published: December 2015
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
